Sagent Pharmaceuticals IPO Advisory

IPO Research - IPO Boutique

<< Return Home

Subscribe Now
  IPO Boutique Blog
IPO Central
  IPO Calendar
  IPO Pipeline
  Track Record
  2015 IPOs
  2014 IPOs
  2013 IPOs
  2012 IPOs
  2011 IPOs
  2010 IPOs
  Last 10 IPO's & Quotes
  Sample IPO
  Rating Scale
  IPO Primer
  Current Week
  Track Record
  2015 Secondaries
  2014 Secondaries
  2013 Secondaries
  2012 Secondaries
  2011 Secondaries
  2010 Secondaries
  Secondaries Primer
International publications
quoting IPO Boutique
founder Scott Sweet
General Info
  About Us
  Contact Us
  Site Map
  A Touch of Humor

For IPO Boutique's "scale of 1 to 5" BUY rating on Sagent Pharmaceuticals, and our comprehensive analysis, click the "Buy Market Research" link.
Price Range
Issue Price
Trade Date
Sagent PharmaceuticalsSGNT Last trade $23.64 $16.00 $18.254.4 million9/11/2013
Morgan Stanley, BofA Merrill Lynch, Jefferies & Co.

Sagent Pharmaceuticals Historical Chart - Click chart for current quote

About Sagent Pharmaceuticals (adapted from Sagent Pharmaceuticals prospectus):
Sagent Pharmaceuticals is an injectable pharmaceutical company that develops and sources products that are sold primarily in the United States through their sales and marketing team. With a primary focus on generic injectable pharmaceuticals, Sagent currently offers customers a range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled, ready-to-use syringes, medical devices and premix bags, and Sagent generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience.

Sagent Pharmaceuticals' management team includes industry veterans who have previously served critical functions at other injectable pharmaceutical companies and have long-standing relationships with customers, regulatory agencies and suppliers.

This description is adapted from Sagent prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

Share this IPO Profile:

IPO Boutique aggregates information on public companies and private companies, such as Sagent "SGNT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Need a recommendation? Visit our Testimonials page and see over 200 investors singing our praises.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription

© 2005 - 2015 IPO Boutique. All Rights Reserved